Post-marketing Safety Surveillance Program in HIV-infected Children Exposed to Atazanavir in Europe
Phase of Trial: Phase IV
Latest Information Update: 05 Jan 2015
At a glance
- Drugs Atazanavir (Primary)
- Indications HIV infections
- Focus Adverse reactions
- Sponsors Bristol-Myers Squibb
- 05 Jan 2015 Last checked against ClinicalTrials.gov record.
- 26 Feb 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Sep 2011 Additional locations identified as reported by ClinicalTrials.gov.